Am J Perinatol 2022; 39(08): 803-807
DOI: 10.1055/s-0041-1740011
SMFM Fellowship Series Article

Risk Factors for Adverse Maternal Outcomes following Expectantly Managed Preterm Prelabor Rupture of Membranes

Alice J. Darling
1   Duke University, School of Medicine, Durham, North Carolina
,
1   Duke University, School of Medicine, Durham, North Carolina
,
Gregory E. Zemtsov
2   Duke University Hospital, Department of Obstetrics and Gynecology, Durham, North Carolina
,
Maria Small
2   Duke University Hospital, Department of Obstetrics and Gynecology, Durham, North Carolina
,
Matthew R. Grace
3   Vanderbilty University Hospital, Department of Obstetrics and Gynecology, Maternal Fetal Medicine, Nashville, Tennessee
,
2   Duke University Hospital, Department of Obstetrics and Gynecology, Durham, North Carolina
,
Sarah K. Dotters-Katz
2   Duke University Hospital, Department of Obstetrics and Gynecology, Durham, North Carolina
› Author Affiliations
Funding None.

Abstract

Objective We sought to characterize the incidence and risk factors associated with developing maternal morbidity following preterm prelabor rupture of membranes.

Study Design Retrospective case–control study of patients with preterm prelabor rupture of membranes at a single institution from 2013 to 2019 admitted at ≥23 weeks gestational age. The primary outcome was a composite of maternal morbidity which included: death, sepsis, intensive care unit (ICU) admission, acute kidney injury, postpartum dilation and curettage, postpartum hysterectomy, venous thromboembolism, postpartum hemorrhage, postpartum wound complication, postpartum endometritis, pelvic abscess, postpartum pneumonia, readmission, and/or need for blood transfusion were compared with patients without above morbidities. Severe morbidity was defined as: death, ICU admission, venous thromboembolism, acute kidney injury, postpartum hysterectomy, sepsis, and/or transfusion >2 units. Demographics, antenatal, and delivery characteristics were compared between patients with and without maternal morbidity. Bivariate statistics and regression models were used to compare outcomes and calculate adjusted odd ratios.

Results Of 361 included patients, 64 patients (17.7%) experienced maternal morbidity and nine (2.5%) had severe morbidity. Patients who experienced maternal morbidity were significantly (p < 0.05) more likely to be older, have private insurance, have BMI ≥40, have chorioamnionitis at delivery, and undergo cesarean or operative vaginal delivery when compared with patients who did not experience morbidity. After controlling for confounders, cesarean delivery (aOR 2.38, 95% CI[1.30,4.39]), body mass index ≥40 at admission (aOR 2.54, 95% CI[1.12,5.79]), private insurance (aOR 3.08, 95% CI[1.54,6.16]), and tobacco use (aOR 3.43, 95% CI[1.58,7.48]) were associated with increased odds of maternal morbidity.

Conclusion In this cohort, maternal morbidity occurred in 17.7% of patients with preterm prelabor rupture of membranes. Private insurance, body mass index ≥40, tobacco use, and cesarean delivery were associated with higher odds of morbidity. These data can be used in counseling and to advocate for smoking cessation.

Key Points

  • 17.7% of patients with PPROM experienced maternal morbidity.

  • BMI ≥40 was associated with higher odds of maternal morbidity.

  • Tobacco use and cesarean delivery were associated with higher odds of maternal morbidity.

Note

Findings of this study were presented in part as a virtual poster presented at the SMFM 41st Annual Pregnancy Meeting January 19-30th, 2021.




Publication History

Received: 29 June 2021

Accepted: 06 October 2021

Article published online:
28 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Waters TP, Mercer B. Preterm PROM: prediction, prevention, principles. Clin Obstet Gynecol 2011; 54 (02) 307-312
  • 2 Menon R, Richardson LS. Preterm prelabor rupture of the membranes: a disease of the fetal membranes. Semin Perinatol 2017; 41 (07) 409-419
  • 3 Reddy UM, Rice MM, Grobman WA. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Serious maternal complications after early preterm delivery (24-33 weeks' gestation). Am J Obstet Gynecol 2015; 213 (04) 538.e1-538.e9
  • 4 Dotters-Katz SK, Panzer A, Grace MR. et al. Maternal morbidity after previable prelabor rupture of membranes. Obstet Gynecol 2017; 129 (01) 101-106
  • 5 Harris PA, Taylor R, Minor BL. et al; REDCap Consortium. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208
  • 6 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
  • 7 How Does CDC Identify Severe Maternal Morbidity? Reproductive Health, Centers for Disease Control and Prevention, 26 Dec. 2019 https://www.cdc.gov/reproductivehealth/maternalinfanthealth/smm/severe-morbidity-ICD.htm
  • 8 Blanc J, Resseguier N, Goffinet F. et al. Association between gestational age and severe maternal morbidity and mortality of preterm cesarean delivery: a population-based cohort study. Am J Obstet Gynecol 2019; 220 (04) 399.e1-399.e9
  • 9 Kawakita T, Landy HJ. Surgical site infections after cesarean delivery: epidemiology, prevention and treatment. Matern Health Neonatol Perinatol 2017; 3: 12 . Published 2017 Jul 5
  • 10 Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 188: prelabor rupture of membranes. Obstet Gynecol 2018; 131 (01) e1-e14
  • 11 Bond DM, Middleton P, Levett KM. et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev 2017; 3 (03) CD004735 . Published 2017 Mar 3
  • 12 Buchanan C, Nahhas GJ, Guille C, Cummings KM, Wheeler C, McClure EA. Tobacco use prevalence and outcomes among perinatal patients assessed through an “opt-out” cessation and follow-up clinical program. Matern Child Health J 2017; 21 (09) 1790-1797